Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment.
| Image |  |
|---|---|
| Description | scientific article published on 20 May 2017 |
| Author/s |
author: Michel D Crema Andrew Kompel |
| Publication date | May 20, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |